XML 62 R43.htm IDEA: XBRL DOCUMENT v3.22.0.1
FAIR VALUE MEASUREMENT AND FINANCIAL INSTRUMENTS - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Fair Value, Option, Quantitative Disclosures [Line Items]              
Contingent consideration liability, measurement input 0.080 0.075 0.066 0.074 0.080 0.084  
License agreement, royalty rate 2.00%       2.00%    
Change in fair value of contingent consideration $ (4,600) $ (114,000) $ 13,600 $ 48,160 $ (56,840) $ (11,180) $ 71,620
Minimum              
Fair Value, Option, Quantitative Disclosures [Line Items]              
Probability of achieving clinical and regulatory milestones 45.00%       45.00%    
Maximum              
Fair Value, Option, Quantitative Disclosures [Line Items]              
Probability of achieving clinical and regulatory milestones 55.00%       55.00%    
Discount Rate              
Fair Value, Option, Quantitative Disclosures [Line Items]              
Weighted-average cost of capital 9.30% 8.60% 6.80% 7.80% 9.30% 8.80%  
Discount Rate | Minimum              
Fair Value, Option, Quantitative Disclosures [Line Items]              
Contingent consideration liability, measurement input 0.080       0.080 0.084  
Discount Rate | Maximum              
Fair Value, Option, Quantitative Disclosures [Line Items]              
Contingent consideration liability, measurement input 0.093       0.093 0.088